Your News

"Your News" is a collection of news stories, articles and blog posts submitted to the Shore News Network from the general public, local businesses, community organizations and pretty much the entire world. At Shore News Network, everyone can be a journalist and report news. To do so, send your news to news@shorenewsnetwork.com. The opinions expressed in this column are those of the author and do not represent the position or opinions of Shore News Network.

GOP Leadership on the “Island” of New Jersey

Incompetence or Deliberate? Op-Ed by Rob Kovic, Esq. In a new low on the competence scale, the New Jersey GOP just lost the right to send 37 delegates to the 2024 Republican National Convention in Milwaukee, Wisconsin. NJ was supposed to send…

Pope Benedict remembered at Newark’s Cathedral Basilica of the Sacred Heart

By Michael Quinn, Arch Diocese of Newark Newark, N.J. – Though some might feel saddened while reflecting on Pope Emeritus Benedict XVI’s passing, Cardinal Joseph W. Tobin, C.Ss.R., Archbishop of Newark, told those attending a January 12 Memorial Mass that…

New Jersey based Barter Saves continues growth with the acquisition of Florida barter group

BarterSaves, New Jersey’s largest independently-owned Barter Exchange has gotten even bigger. On January 9, the company acquired BarterFirst International based out of Florida, serving businesses in Orlando and the surrounding area for…

West Long Branch to preserve historic Fishtown fire house as museum

PRESS RELEASE BY CITY of WEST LONG BRANCH Long Branch introduced an ordinance this evening to purchase the Oliver Byron Fire House with the goal of creating the Long Branch Fire and…

The Vitamin Shoppe Partners with Baranova27 to Donate over Two Tons of Protein Bars and Nutritious Snacks to Communities Impacted by the War in Ukraine

Sharon Leite, CEO of The Vitamin Shoppe, commented: “Our teams at The Vitamin Shoppe are honored to be able to contribute to the refugees, frontline heroes, and extraordinary citizens of Ukraine in…

HSS to Honor Renowned Sports Medicine Surgeon David W. Altchek, MD, and Philanthropist Andreas C. Dracopoulos at The 2022 Tribute Dinner

NEW YORK, June 6, 2022 — Hospital for Special Surgery (HSS) will host its 37th Tribute Dinner on June 6 at the American Museum of Natural History in New York City. The event…

Mohegan Appoints Heather Menzano as Vice President, Web Communications to Spearhead Digital Marketing Communications and Growth

“Heather joins us at a pivotal time. We welcome her to our executive team as we continue to gravitate toward cutting-edge technology, digital solutions and experiences for casino gamers and entertainment-seekers around…

Jackpocket Named Official Digital Lottery Partner of the Colorado Rockies

With this partnership, Jackpocket will be hosting ticket giveaways, free branded merchandise, and also offering unique VIP experiences for Rockies fans. New players will be able to enter the unique code “ROCKIES”…

Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English

BEDMINSTER, N.J., 3 juin 2022 — Jubilant Therapeutics Inc., une société de thérapies de précision au stade clinique qui fait progresser les petites molécules thérapeutiques pour répondre à des besoins médicaux non…

CytoSorbents s’associe à Nikkiso pour assurer la distribution de la pompe à sang d’hémoperfusion PureADJUST et de ses consommables dans 14 pays USA – English Deutschland – Deutsch EspaÃ±a – espaÃ±ol France – FranÃ§ais

Le modèle commercial de la pompe à sang autonome devrait permettre une utilisation étendue et une adoption accrue de CytoSorb ® PRINCETON, New Jersey, 3 juin 2022 — CytoSorbents Corporation (NASDAQ: CTSO), un leader dans…

New HSS Study Defines Disease Characteristics for Patients with Undifferentiated Connective Tissue Disease

COPENHAGEN, Denmark, June 2, 2022 — A new study by researchers at Hospital for Special Surgery (HSS) has further clarified the clinical manifestations of undifferentiated connective tissue disease (UCTD). The findings were…

Winston & Strawn Highlights Recent Court Victories for LGBTQ+ Rights

CHICAGO, June 2, 2022 — Winston & Strawn LLP kicked off the firm’s recognition of Pride Month with three high-profile legal victories advancing rights and protections for the LGBTQ+ community. Winston &…

Tracy Bradford Promoted to President of Seminole Hard Rock Support Services

Seminole Hard Rock Support Services was established in 2017 to consolidate and coordinate multiple staff functions of Hard Rock International and Seminole Gaming, which share corporate office space at 5701 Stirling Road,…

RxBIO launches NeoGen Plasma Skin Rejuvenation in the USA – NeoGen Plasma brings a unique solution to treat the whole skin architecture

The NeoGenPSR system uses nitrogen plasma technology which is clinically proven to resurface, regenerate and tighten all skin types in one treatment. This device treats the whole skin architecture, whilst keeping the…

“Agent PHL Brokers 75-Unit Investment Sale in Philadelphia for $21,338,000”

McManus said, “Kensington Courts is like a micro-city nestled high above the most popular residential submarket in Philly today – Fishtown/Kensington. The Riverwards Group masterfully transformed a 185,000 SF vacant parcel into…

Record Scholarship Amount for a Record Number of Students

Award ceremonies for the scholarship program took place on June 1 at the Consulate General of the Republic of Poland in New York and on June 2 at the Cracovia Manor in…

Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English Deutschland – Deutsch

BEDMINSTER, N.J., 3 juin 2022 — Jubilant Therapeutics Inc., une société de thérapies de précision au stade clinique qui fait progresser les petites molécules thérapeutiques pour répondre à des besoins médicaux non…

Jubilant Therapeutics Inc. berichtet auf der Jahrestagung 2022 der American Society of Clinical Oncology (ASCO) über die Entwicklung oral verfügbarer und ins Gehirn eindringender niedermolekularer PD-L1-Inhibitoren Deutschland – Deutsch USA – English France – Français

BEDMINSTER, N.J., 3. Juni 2022 — Jubilant Therapeutics Inc., ein Unternehmen für Präzisionstherapeutika in der klinischen Phase, das niedermolekulare Therapeutika für ungedeckten medizinischen Bedarf in der Onkologie und bei Autoimmunerkrankungen entwickelt, gab…

CytoSorbents s’associe à Nikkiso pour assurer la distribution de la pompe à sang d’hémoperfusion PureADJUST et de ses consommables dans 14 pays France – Français USA – English Deutschland – Deutsch España – español

Le modèle commercial de la pompe à sang autonome devrait permettre une utilisation étendue et une adoption accrue de CytoSorb ® PRINCETON, New Jersey, 3 juin 2022 — CytoSorbents Corporation (NASDAQ: CTSO), un leader dans…

Cambrex fait l’acquisition du leader européen de stockage de stabilité Q1 Scientific France – Français USA – English USA – English Deutschland – Deutsch Latin America – español Brazil – Português

« Le stockage et la mise à l’essai de la stabilité sont des éléments essentiels de la mise au point et de la commercialisation de nouveaux traitements médicamenteux. Q1 Scientific apporte des moyens…

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., June 3, 2022 — Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting…

PBF Energy to Participate in the Bank of America Energy Credit Conference

PARSIPPANY, N.J., June 3, 2022 — PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the Bank of America Energy Credit Conference on June 8, 2022.…

Taiho Oncology Announces Updated Efficacy and Safety Data for Futibatinib in Cholangiocarcinoma at 2022 ASCO Annual Meeting

These data are part of a New Drug Application that has been granted priority review by the U.S. Food and Drug Administration PRINCETON, N.J., June 3, 2022 — Taiho Oncology, Inc. announced…

LIGHTNING EMOTORS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lightning eMotors, Inc. – ZEV

NEW ORLEANS, June 3, 2022 — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF…

Previous 1 … 32 33 34 35 36 … 172 Next